Deals of the day-Mergers and acquisitions

(Adds: Revance Therapeutics, Scotiabank, Tourmaline Oil, Synopsys, International Distributions Services Updates: Bharti Enterprises)

Aug 12 (Reuters) – The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:

** Anti-wrinkle injection maker Revance Therapeutics has agreed to bought by privately held Crown Laboratories in a deal valued at $924 million, including debt, they said, seeking a bigger presence in the aesthetic products market.

** Scotiabank is buying a 14.9% stake in American regional lender KeyCorp for $2.8 billion, as the Canadian bank taps into the stressed U.S. banking sector for growth outside its saturated home market.

** India’s Bharti Enterprises said it would acquire a 24.5% stake in BT, worth 3.2 billion pounds ($4 billion), to buy out the British company’s top investor Patrick Drahi as his Altice group speeds up asset sales to cut its debt burden.

** Canada’s Tourmaline Oil said it will acquire Crew Energy in a C$1.3 billion ($947.52 million) all-stock deal, which includes debt, to boost its presence in the Montney shale play in Alberta.

** UK’s competition watchdog said it was looking into whether chip design software maker Synopsys’ $35 billion acquisition of Ansys would affect competition in Britain.

** International Distributions Services, the parent company of Royal Mail, announced that its parcel services business, GLS, will sell its U.S. freight divisions to California-based DC Logistics.

** Gold Fields Ltd has agreed to acquire Osisko Mining for C$2.16 billion ($1.57 billion), it said, barely two years after an attempt to buy another Canadian miner was scuppered by a rival offer.

** New Zealand construction firm Fletcher Building said it would sell its Australian plumbing supplies and distribution business Tradelink for A$170 million ($112 million) to Australia-based Metal Manufactures Pty. (Compiled by Rajarshi Roy and Pritam Biswas in Bengaluru)

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html